Biosimilars Market Regional News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Biosimilars market regional. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Biosimilars Market Regional Today - Breaking & Trending Today

Global Filgrastim Biosimilars Market Report 2020: COVID-19 Impacts, Growth and Changes


Share this article
Share this article
ResearchAndMarkets.com s offering.
Major players in the filgrastim biosimilars market are Cadila Pharmaceuticals, Dr. Reddy s Laboratories, Intas Biopharmaceuticals, Sandoz, Amgen Inc., Dr. Reddy s Laboratories Ltd, Intas Pharmaceuticals, Emcure Pharmaceuticals Ltd., Biocon and Aryogen Biopharma.
The global filgrastim biosimilars market is expected to decline from $511.15 million in 2019 to $445.04 million in 2020 at a compound annual growth rate (CAGR) of -12.93%. The decline is mainly due to the COVID-19 outbreak that has led to restrictive containment measures involving social distancing, remote working, and the closure of industries and other commercial activities resulting in operational challenges. The entire supply chain has been disrupted, impacting the market negatively. The market is then expected to recover and reach $751.96 billion in 2023 at a CAGR of 19.11%. ....

Adello Biologics , Kashiv Biosciences , Aryogen Biopharma , Kashiv Pharma , Laura Wood , Reliance Life Sciences Pvt , Biosimilar Awareness Initiative , Biosimilar Medicines Association , Custom Research , Roche Ltd , Abbott Laboratories Inc , Teva Pharmaceuticals Industries , Office Hours Call , Emcure Pharmaceuticals Ltd , Drug Administration , Claris Lifesciences , E St Office Hours Call , Amgen Inc , Intas Pharmaceuticals , European Medicines Agency , Reddy Laboratories Ltd , Cadila Pharmaceuticals , Biosimilars Global Market Report , Intas Biopharmaceuticals , Laboratories Ltd , Biosimilar Action Plan ,

Global Oncology Biosimilars Market (2020 to 2026) - Industry Analysis, Trends, Market Size, and Forecasts


Share this article
Share this article
ResearchAndMarkets.com s offering.
The report on the global oncology biosimilars market provides qualitative and quantitative analysis for the period from 2018 to 2026. The report predicts the global oncology biosimilars market to grow with a CAGR of 30.25m% over the forecast period from 2020-2026. The study on oncology biosimilars market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific, and RoW for the period of 2018 to 2026.
The report on oncology biosimilars market is a comprehensive study and presentation of drivers, restraints, opportunities, demand factors, market size, forecasts, and trends in the global oncology biosimilars market over the period of 2018 to 2026. Moreover, the report is a collective presentation of primary and secondary research findings. ....

United States , Laura Wood , Custom Research , Biocad Biopharmaceutical Co , Office Hours Call , Sandoz International Gmb , Momenta Pharmaceuticals Inc , Research Methods , Reddy Laboratories , Company Profiles , E St Office Hours Call , Pfizer Inc , Amgen Inc , Porter Five Forces Analysis , Roche Holding , Mylan Pharmaceuticals Inc , Biosimilars Market , Global Industry Analysis , Market Size , North America , Growth Matrix , Topics Covered , Biosimilars Market Regional , Oncology Biosimilars Market , Oncology Biosimilars , Five Forces ,